Latest Financial Results

Q2 2022

Quarterly Results

June 30, 2022

Stock Quote

Titan Pharmaceuticals, Inc. Nasdaq: TTNP Loading...
Volume Loading...
Day Low/High Loading...
52 Week Low/High Loading...

Company Overview

Titan is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides the potential for an efficacy and/or safety benefit. Titan's lead product in development is an implant for the treatment of moderate-to severe-chronic pruritus.

Officers & Directors

name

Kate Beebe DeVarney, Ph.D.

President and Chief Operating Officer

Dr. DeVarney has served as a Director of Titan’s Board of Directors since 2019 and in October 2020, she became Titan’s President and Chief Operating Officer.  She previously served as Chief Scientific Officer and has been with the…

View Full Bio
name

Marc Rubin, MD

Dr. Rubin has served as Titan's Executive Chairman of the Board of Directors since 2009, after previously holding the position of CEO. Prior to joining Titan, Dr. Rubin was Head of Global Research and Development for Bayer Schering Pharma,…

View Full Bio
name

Kate Beebe DeVarney, Ph.D.

President and Chief Operating Officer

Dr. DeVarney has served as a Director of Titan’s Board of Directors since 2019 and in October 2020, she became Titan’s President and Chief Operating Officer.  She previously served as Chief Scientific Officer and has been with the…

View Full Bio
name

Joseph A. Akers

Mr. Akers has served as president of Bayer's hematology/cardiology business, where he oversaw the core of Bayer's specialty pharmaceuticals development, with significant products in hematology and specialty cardiology. Mr. Akers also…

View Full Bio
name

M. David MacFarlane, PhD

Dr. MacFarlane has been a Director of Titan Pharmaceuticals since May 2002. Dr. MacFarlane served as Vice President and Responsible Head of Regulatory Affairs of Genentech, Inc. from 1989 until his retirement in August 1999. Prior to…

View Full Bio
name

James R. McNab, Jr.

Mr. McNab, an entrepreneur experienced in building and growing companies, is co-founder and chairman of Curis, a publicly traded oncology company that partnered with Roche to develop and commercialize a first-in-class hedgehog inhibitor…

View Full Bio

David E. Lazar

Interim Chairman of the Board of Directors and Chief Executive Officer

Mr. Lazar serves as Titan’s Interim Chairman of the Board of Directors and Chief Executive Officer. He previously served as the Chief Executive Officer of Custodian Ventures LLC, a company which specializes in assisting distressed…

View Full Bio

Avraham Ben-Tzvi

Mr. Ben-Tzvi is the Founder of ABZ Law Office, a boutique Israeli law firm specializing in outsourced general counsel services for publicly traded as well as private companies and corporations, Investments & Securities Laws, Commercial…

View Full Bio

Eric Greenberg

Mr. Greenberg has over 40 years of capital markets experience. As a trader and portfolio manager at hedge funds, his areas of expertise included the development of trading strategies, portfolio management and deal structuring. Mr.…

View Full Bio

David Natan

Mr. Natan currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. In…

View Full Bio

Matthew C. McMurdo

Mr. McMurdo currently serves as Managing Member of McMurdo Law Group, LLC, a corporate and securities law practice, since 2010. Previously, Mr. McMurdo was a Partner at Nannarone & McMurdo, LLP, a boutique law firm, from 2008 to 2010. In…

View Full Bio

Peter L. Chasey

Mr. Chasey serves as the Owner of Chasey Law Offices, a law practice specializing in personal litigation, business litigation and commercial law, since founding the practice in 2005. Earlier in his career, Mr. Chasey served as staff…

View Full Bio